tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SONN Stock Latest News

Sonnet Biotherapeutics Holdings Inc trading resumes
The FlySonnet Biotherapeutics Holdings Inc trading resumes
6h ago
SONN
Sonnet says SON-1010 demonstrates ‘strong safety profile’ in atezolizumab combo
PremiumThe Fly
Sonnet says SON-1010 demonstrates ‘strong safety profile’ in atezolizumab combo
7h ago
SONN
Sonnet Biotherapeutics Holdings Inc trading halted, news pending
PremiumThe Fly
Sonnet Biotherapeutics Holdings Inc trading halted, news pending
7h ago
SONN
Sonnet BioTherapeutics Announces New Interim CEO Appointment
PremiumCompany Announcements
Sonnet BioTherapeutics Announces New Interim CEO Appointment
3d ago
8K
SONN
Sonnet BioTherapeutics announces passing of founder, CEO Pankaj Mohan
PremiumThe Fly
Sonnet BioTherapeutics announces passing of founder, CEO Pankaj Mohan
3d ago
SONN
Sonnet BioTherapeutics completes first safety review of SON-1010
PremiumThe FlySonnet BioTherapeutics completes first safety review of SON-1010
9d ago
SONN
Sonnet BioTherapeutics Secures Second Patent for IL-18 Variant
Premium
Company Announcements
Sonnet BioTherapeutics Secures Second Patent for IL-18 Variant
16d ago
8K
SONN
Sonnet BioTherapeutics receives notice of allowance for U.S. patent for IL-18
Premium
The Fly
Sonnet BioTherapeutics receives notice of allowance for U.S. patent for IL-18
16d ago
SONN
Sonnet BioTherapeutics Highlights Promising SON-1010 Data
PremiumCompany Announcements
Sonnet BioTherapeutics Highlights Promising SON-1010 Data
1M ago
8K
SONN
Sonnet BioTherapeutics presents data on SON-1010
PremiumThe Fly
Sonnet BioTherapeutics presents data on SON-1010
1M ago
SONN
Sonnet BioTherapeutics Advances Antibody Drug Conjugate Platform
PremiumCompany Announcements
Sonnet BioTherapeutics Advances Antibody Drug Conjugate Platform
1M ago
8K
SONN
Sonnet announces ADC platform available for drug discovery partnerships
PremiumThe Fly
Sonnet announces ADC platform available for drug discovery partnerships
1M ago
SONN
Sonnet Biotherapeutics Reports Increased Revenue and Strategic Developments
PremiumCompany AnnouncementsSonnet Biotherapeutics Reports Increased Revenue and Strategic Developments
2M ago
SONN
Sonnet BioTherapeutics appoints McAndrew as Chief Business Officer
Premium
The Fly
Sonnet BioTherapeutics appoints McAndrew as Chief Business Officer
2M ago
SONN
Sonnet BioTherapeutics reports Q1 EPS ($1.56) vs ($2.46) last year
Premium
The Fly
Sonnet BioTherapeutics reports Q1 EPS ($1.56) vs ($2.46) last year
2M ago
SONN
Sonnet BioTherapeutics appoints McAndrew as CBO, Griffith as CFO
PremiumThe Fly
Sonnet BioTherapeutics appoints McAndrew as CBO, Griffith as CFO
2M ago
SONN
Sonnet BioTherapeutics Secures EU Patent for FHAB Technology
PremiumCompany Announcements
Sonnet BioTherapeutics Secures EU Patent for FHAB Technology
2M ago
8K
SONN
Sonnet BioTherapeutics further expands global IP portfolio
PremiumThe Fly
Sonnet BioTherapeutics further expands global IP portfolio
2M ago
SONN
Sonnet BioTherapeutics files to sell 2M shares of common stock for holders
PremiumThe Fly
Sonnet BioTherapeutics files to sell 2M shares of common stock for holders
2M ago
SONN
Sonnet BioTherapeutics Expands Phase 1 Study for SON-1010
PremiumCompany AnnouncementsSonnet BioTherapeutics Expands Phase 1 Study for SON-1010
2M ago
8K
SONN
Sonnet BioTherapeutics expands Phase 1 SB101 trial
Premium
The Fly
Sonnet BioTherapeutics expands Phase 1 SB101 trial
2M ago
SONN
Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
Premium
The Fly
Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
4M ago
SONN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >